Fresh analysis indicates that patients who come off new weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle plans.
Findings released in a prominent health publication shows that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month once they quit.
"Users using these treatments need to be aware of the risk of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight within about a year and a half.
Analyzing Therapies
The analysis, which reviewed dozens of studies involving over 9,000 of participants, compared the effects of these new drugs with other pills.
Researchers emphasize that people who shed pounds through diet and exercise generally see a less rapid creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Fast Regain
Experts suggest the way of the injections is key to understanding the heightened weight return.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone levels far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making overeating much more probable."
A Chronic Condition?
The NHS recommend the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Professionals contend that, considering the high risk of weight regain, the treatment is often life-long.
This perspective is reinforced by pharmaceutical companies, who say that the results "highlight the chronic character of excess weight," similar to managing conditions like diabetes.
Patient Testimonies
People who have come off the medication describe a intense resurgence of cravings.
"It was like a switch activating and you're instantly extremely hungry," said an individual.
This difficulty is exacerbated if patients have not adopted lasting dietary or behavioural modifications during treatment.
Growing Interest
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a magic fix and long-term success likely depends on ongoing behavioural management.
